Essential cookies by default. The browser ID, load-time metrics and error replays only run if you choose "Accept all".
Head-to-head evidence comparison — which supplement is right for you?
Plant Sterols vs Saccharomyces Boulardii: Saccharomyces Boulardii has the stronger overall evidence (8.5 vs 7/10); the best pick depends on your goals. Take the 2-minute quiz for a pick tailored to your goals.
Saccharomyces Boulardii wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
Top outcomes
Verdict
Helped
4 of 4 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Plant Sterols and Saccharomyces Boulardii have evidence — compare verdict strength side-by-side.
A source-matched dose range is not available for this product and use.
Count added plant sterols and plant stanols together when applying the separate intake warning. Do not treat the two entries as separate allowances.
With meals
If use is appropriate, choose an enriched food or supplement formulation with evidence for LDL lowering and a clearly labelled amount of plant sterols, expressed as free sterols, per portion.
A source-matched dose range is not available for this product and use.
With or without food, At least 2 hours away from antifungals
Capsules (lyophilized)
2-3 weeks
4 weeks
Not established
Not established
During use
1-3 days
1-2 weeks
Efficacy of phytosterols for reduction of cardiometabolic risk factors: An umbrella review of systematic reviews and meta-analyses and updated dose-response meta-analyses of randomized trials.
Clinical Nutrition (2026) · Meta-Analysis
14 systematic reviews and meta-analyses of randomised trials in adults taking phytosterol supplements or enriched foods were included.
LDL-cholesterol-lowering effect of plant sterols and stanols across different dose ranges: a meta-analysis of randomised controlled studies.
British Journal of Nutrition (2014) · Meta-Analysis
124 randomised studies (201 strata) were included, with an average dose of 2.1 g a day (range 0.2 to 9.0).
Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake.
Journal of Nutrition (2009) · Meta-Analysis
84 randomised trials with 141 trial arms in adults were included.
Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis
Frontiers in cellular and infection microbiology (2025) · Meta-Analysis · n=5036
Meta-analysis of 19 studies with 5,036 people with H. pylori infection, adding S. boulardii to standard eradication therapy.
Probiotics for treating acute infectious diarrhoea
The Cochrane database of systematic reviews (2020) · Meta-Analysis · n=12127
Effect size was similar in the sensitivity analysis and marked heterogeneity persisted.
The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes
Gut microbes (2024) · Meta-Analysis · n=2871
This review aims to analyze available evidence from human-controlled trials to determine the effect size of probiotic interventions in decolonizing AMR pathogenic bacteria from the gut.
One pooled estimate across the trials and doses shown. Patients receiving bismuth quadruple eradication therapy, random-effects pooled. The subgroups overlap in study count (2 and 10 studies of 10 trials), so a study can sit in both rows, and the rows are not a head-to-head dose comparison. Source: PMID 40251486.
Both points come from a meta-analysis of 10 randomised trials adding S. boulardii to bismuth quadruple therapy (PMID 40251486), whose dose subgroups found the same gain in eradication at 500 mg a day (RR 1.10, 95% CI 1.03 to 1.17) and 1000 mg a day (RR 1.08, 95% CI 1.03 to 1.12). The reported eradication risk ratios and confidence intervals are study summaries, not individual dose-response estimates. A lower overall adverse-event risk ratio does not establish per-dose adverse-effect probabilities. The authors recommend 500 mg a day for more than 10 days. The effect is as an add-on to antibiotics only, and doses are in mg of product, not CFU.
Saccharomyces Boulardii has a higher evidence score (8.5/10 vs 7/10) and wins in 2 of 3 categories.
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.